| __timestamp | Eli Lilly and Company | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 382096000000 |
| Thursday, January 1, 2015 | 4796400000 | 345927000000 |
| Friday, January 1, 2016 | 5243900000 | 312303000000 |
| Sunday, January 1, 2017 | 5281800000 | 325441000000 |
| Monday, January 1, 2018 | 5051200000 | 368298000000 |
| Tuesday, January 1, 2019 | 5595000000 | 492381000000 |
| Wednesday, January 1, 2020 | 6085700000 | 455833000000 |
| Friday, January 1, 2021 | 7025900000 | 526087000000 |
| Saturday, January 1, 2022 | 7190800000 | 633325000000 |
| Sunday, January 1, 2023 | 9313400000 | 729924000000 |
| Monday, January 1, 2024 | 14271000000 | 729924000000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Eli Lilly and Company and Takeda Pharmaceutical Company Limited have demonstrated contrasting strategies in their R&D expenditures.
Eli Lilly's R&D spending has seen a steady increase, growing by approximately 97% from 2014 to 2023. This reflects their commitment to pioneering new treatments and maintaining a competitive edge. In contrast, Takeda's R&D investments have been significantly higher, with a staggering 91% increase over the same period, highlighting their aggressive approach to expanding their research capabilities.
While Eli Lilly's R&D expenses reached a peak of $9.3 billion in 2023, Takeda's investments soared to $729 billion, showcasing their dominance in the sector. However, data for 2024 is incomplete, leaving room for speculation on future trends.
Comparing Innovation Spending: Eli Lilly and Company and Novo Nordisk A/S
Research and Development Investment: Eli Lilly and Company vs argenx SE
Eli Lilly and Company or Halozyme Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and BeiGene, Ltd.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Dynavax Technologies Corporation
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and MiMedx Group, Inc.